Drug Shortage Report for VINORELBINE INJECTION, USP

Last updated on 2019-03-15 History
Report ID 73634
Drug Identification Number 02431130
Brand name VINORELBINE INJECTION, USP
Common or Proper name 10 mg/ml Vinorelbine (as vinorelbine tartrate)
Company Name GENERIC MEDICAL PARTNERS INC
Active Ingredient(s) VINORELBINE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5 ML IN CLEAR GLASS VIAL
ATC code L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-02-25
Actual start date
Estimated end date 2019-03-14
Actual end date 2019-03-14
Shortage status Resolved
Updated date 2019-03-15
Company comments The latest batch of Vinorelbine 10mg/ml 5 ml vials has cleared QA and have been released. Regular supply of both Vinorelbine 10mg/ml 5 ml and 1 ml vials has now been re-established. The allocation process set in place for 5 ml vials with contracted accounts has been removed. GMP did not have a complete shortage during the allocation process. There is already an existing supply of Vinorelbine 10mg/ml 1 ml vials to meet usual national requirements.
Health Canada comments
Contact Address 251 CONSUMERS ROAD
TORONTO, ONTARIO
CANADA M2J 4R3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-03-15 English Compare
v9 2019-03-14 French Compare
v8 2019-03-14 English Compare
v7 2019-03-14 English Compare
v6 2019-03-04 French Compare
v5 2019-03-04 English Compare
v4 2019-02-26 English Compare
v3 2019-01-25 French Compare
v2 2019-01-25 English Compare
v1 2019-01-25 English Compare